Novartis Investigative Site

Tsukubo-gun, Okayama-ken 701-0304

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Rheumatoid Arthritis

Studies at this site

• Dose Finding Study for QAW039 in Asthma — Completed
• Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents — Completed